Literature DB >> 16319069

A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors.

Sébastien Marion1, Robert H Oakley, Kyeong-Man Kim, Marc G Caron, Larry S Barak.   

Abstract

beta-Arrestins have been shown to inhibit competitively G protein-dependent signaling and to mediate endocytosis for many of the hundreds of nonvisual rhodopsin family G protein-coupled receptors (GPCR). An open question of fundamental importance concerning the regulation of signal transduction of several hundred rhodopsin-like GPCRs is how these receptors of limited sequence homology, when considered in toto, can all recruit and activate the two highly conserved beta-arrestin proteins as part of their signaling/desensitization process. Although the serine and threonine residues that form GPCR kinase phosphorylation sites are common beta-arrestin-associated receptor determinants regulating receptor desensitization and internalization, the agonist-activated conformation of a GPCR probably reveals the most fundamental determinant mediating the GPCR and arrestin interaction. Here we identified a beta-arrestin binding determinant common to the rhodopsin family GPCRs formed from the proximal 10 residues of the second intracellular loop. We demonstrated by both gain and loss of function studies for the serotonin 2C, beta2-adrenergic, alpha2a)adrenergic, and neuropeptide Y type 2 receptors that the highly conserved amino acids, proline and alanine, naturally occurring in rhodopsin family receptors six residues distal to the highly conserved second loop DRY motif regulate beta-arrestin binding and beta-arrestin-mediated internalization. In particular, as demonstrated for the beta2 AR, this occurs independently of changes in GPCR kinase phosphorylation. These results suggest that a GPCR conformation directed by the second intracellular loop, likely using the loop itself as a binding patch, may function as a switch for transitioning beta-arrestin from its inactive form to its active receptor-binding state.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16319069     DOI: 10.1074/jbc.M508074200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

Review 2.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

3.  Differential signaling by splice variants of the human free fatty acid receptor GPR120.

Authors:  Sarah-Jane Watson; Alastair J H Brown; Nicholas D Holliday
Journal:  Mol Pharmacol       Date:  2012-01-26       Impact factor: 4.436

4.  Ligands and signaling proteins govern the conformational landscape explored by a G protein-coupled receptor.

Authors:  Sophie Mary; Marjorie Damian; Maxime Louet; Nicolas Floquet; Jean-Alain Fehrentz; Jacky Marie; Jean Martinez; Jean-Louis Banères
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-09       Impact factor: 11.205

5.  Desensitization of human CRF2(a) receptor signaling governed by agonist potency and βarrestin2 recruitment.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Sandra Braun; Judith Hernandez-Aranda; Christine C Hudson; Eric Gutknecht; Frank M Dautzenberg; Robert H Oakley
Journal:  Regul Pept       Date:  2013-06-29

Review 6.  Bimolecular fluorescence complementation: lighting up seven transmembrane domain receptor signalling networks.

Authors:  Rachel H Rose; Stephen J Briddon; Nicholas D Holliday
Journal:  Br J Pharmacol       Date:  2009-12-10       Impact factor: 8.739

7.  Disease-causing mutation in GPR54 reveals the importance of the second intracellular loop for class A G-protein-coupled receptor function.

Authors:  Jennifer L Wacker; David B Feller; Xiao-Bo Tang; Mia C Defino; Yuree Namkung; John S Lyssand; Andrew J Mhyre; Xu Tan; Jill B Jensen; Chris Hague
Journal:  J Biol Chem       Date:  2008-09-04       Impact factor: 5.157

8.  The arginine of the DRY motif in transmembrane segment III functions as a balancing micro-switch in the activation of the β2-adrenergic receptor.

Authors:  Louise Valentin-Hansen; Marleen Groenen; Rie Nygaard; Thomas M Frimurer; Nicholas D Holliday; Thue W Schwartz
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

Review 9.  Pharmacosynthetics: Reimagining the pharmacogenetic approach.

Authors:  Martilias S Farrell; Bryan L Roth
Journal:  Brain Res       Date:  2012-10-09       Impact factor: 3.252

10.  An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Authors:  Hongxiang Lan; Martha M Teeter; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.